Yayınlar & Eserler

Makaleler 139
Tümü (139)
SCI-E, SSCI, AHCI (127)
SCI-E, SSCI, AHCI, ESCI (129)
ESCI (2)
Scopus (126)
TRDizin (13)
Diğer Yayınlar (9)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 46

1. The Effect Of Spillover Artefact And Pulmonary Movement To The Calculation Of Hepatopulmonary Shunt Ratio

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri) identifier

2. AC CONDUCTIVITY OF CoFe2O4 NANOPARTICLES SYNTHESIZED BY POLYOL METHOD

IEEE NANO 2015 15th INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY, Rome, İtalya, 27 - 30 Temmuz 2015, ss.271-273, (Tam Metin Bildiri) Creative Commons License identifier identifier

3. INFECTIONS WITH RESPIRATORY VIRUSES IN CHILDREN WITH CANCER IN ISTANBUL

46th IMeeting of the International Society of Pediatric Oncology, Toronto, Kanada, 22 - 25 Ekim 2014, ss.102, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. 18F-FDG PET/CT for Detecting Extensive Disease in Small-Cell Lung Cancer

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

5. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, (Özet Bildiri) identifier identifier

6. The Role of FDG PET/CT Findings in Predicting Survival in Patients with Esophageal Cancer

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

7. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) identifier

8. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

10. The Evaluation of Grade 1 and Grade 2 Gastroenteropancreatic Neuro-Endocrine Tumors with Ga-68 Dotatate PET/BT

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri) identifier

11. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

12. Comparison of Different Scintigraphic Methods in Determination of Recurrence in Medullary Thyroid Carcinoma Patients

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri) identifier

14. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients

World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, İtalya, 22 - 26 Haziran 2013, cilt.68, ss.216, (Özet Bildiri) identifier

16. pediatrik hiv vakalarının değerlendirilmesi

7.ulusal çocuk enfeksiyon hastalıkları kongresi, Türkiye, 27 Nisan - 01 Mayıs 2011 Sürdürülebilir Kalkınma

17. empyema resistant to therapy after swine origin influenza A H1N1 infection

26th international pediatric association congress of pediatrics, İsviçre, 4 - 09 Nisan 2011

18. The use of PET-CT for staging and restaging purpose in malign melanoma: Preliminary results

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) identifier

19. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Viyana, Avusturya, 14 Nisan 2010 - 18 Nisan 2014, ss.238, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

20. PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 14 - 18 Nisan 2010, (Özet Bildiri) identifier identifier

21. Surveillance and oseltamivir resistance of human influenza A virus in Turkey during the 2007-2008 season

12th Annnual Meeting of the European-Society-for=Clinical-Virology, İstanbul, Türkiye, 27 - 30 Eylül 2009, ss.9

22. 12th Annnual Meeting of the European-Society-for=Clinical-Virology

12th Annnual Meeting of the European-Society-for=Clinical-Virology, İstanbul, Türkiye, 27 - 30 Eylül 2009, ss.19, (Tam Metin Bildiri)

23. Surveillance and oseltamivir resistance of human influenza A virus in Turkey during the 2007-2008 season

12th Annnual Meeting of the European-Society-for=Clinical-Virology, İstanbul, Türkiye, 27 - 30 Eylül 2009, cilt.46, (Özet Bildiri) identifier

24. Turkey's influenza surveillance results in 2008-2009 winter season

12th Annnual Meeting of the European-Society-for=Clinical-Virology, İstanbul, Türkiye, 27 - 30 Eylül 2009, cilt.46, (Özet Bildiri) identifier

25. The presence of HCVRNA in the peripheral blood mononuclear cells of the individuals with isolated anti HCV positivity: Is HCV hiding out?

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, İtalya, 23 - 27 Nisan 2008, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

26. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri) identifier

27. Human lung tumor cells modifies rates of CD4+CD25+T regulatory, CD19+CD23+B regulatory cells, CD3+CD95+cells, NK cells and B lymphocytes

7th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, California, Amerika Birleşik Devletleri, 7 - 11 Haziran 2007, cilt.123, (Özet Bildiri) identifier

28. Human lung tumor cells modifles rates of CD4+CD25+T regulatory, CD1 9+CD23+B regulatory cells, CD3+CD95+cells, NK cells and B lymphocytes

7th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, California, Amerika Birleşik Devletleri, 7 - 11 Haziran 2007, cilt.123, (Özet Bildiri) identifier

29. High baseline HBV-DNA is linked to the emergence of adefovir resistance in lamivudine resistant patients

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, İspanya, 11 - 15 Nisan 2007, cilt.46, (Özet Bildiri) identifier

30. Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy

56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005, (Özet Bildiri) identifier

31. Hepatosteatosis in patients with chronic hepatitis B:: Prevalence and the effect on the treatment response rate to α-interferon

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, ss.241-242, (Özet Bildiri) identifier

34. Anti-CCP and anti-keratin antibodies in rheumatoid arthritis, primary Sjogren's syndrome and Wegener's granulomatosis

Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.199-200, (Özet Bildiri) identifier

36. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri) identifier

37. Time to development of chronic liver diseases in a genotype 1 dominant population of chronic hepatitis C virus infection

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.148-149, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

38. Long term results of alpha-interferon monotherapy

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, ss.149, (Özet Bildiri) identifier

39. Relationship between Parkinson's disease and HLA-antigens in Turkish patients

Tissue Typing and Immunosuppression Symposium, Ankara, Türkiye, 19 - 21 Haziran 2002, cilt.60, ss.554, (Özet Bildiri) identifier

41. Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, (Özet Bildiri) identifier

42. The preliminary results of interferon alpha and ribavirin combination therapy in chronic delta hepatitis.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, (Özet Bildiri) identifier

43. Occult HBV infection and YMDD mutants in hemodialysis patients with chronic HCV infection.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, (Özet Bildiri) identifier

45. Deneysel T Hücre aktivasyonu ile Hepatik Hasar Oluşumunun İncelenmesi

III.Ulusal Viral Hepatit Simpozyumu, Ankara, Türkiye, 7 - 09 Kasım 1996, cilt.1, ss.22, (Özet Bildiri)

46. PREVALENCE OF IMMUNOLOGICAL MARKERS OF HEPATITIS-B INFECTION AND IMMUNE-RESPONSE TO VACCINE IN MEDICAL STAFF

SYMP ON PROGRESS IN HEPATITIS B IMMUNIZATION, Paris, Fransa, 3 - 05 Mayıs 1989, cilt.194, ss.255-256, (Tam Metin Bildiri) Sürdürülebilir Kalkınma identifier
Kitaplar 3

1. Parazit Enfeksiyonlarında Patogenez/Antiparazitlere Direnç

Enfeksiyon Patogenezi ve Bağışıklık, Badur S., Abacıoğlu H., Öngen B., Editör, Akademi Kitap Yayınevi, İstanbul, ss.899-908, 2015

2. CHLAMYDİA İNFEKSİYONLARININ TANISINDA PCR TEKNİĞİNİN YERİ

CHLAMYDİAİNFEKSİYONLARI VE TANIDA YERİ, Ağaçfidan A, Badur S., Editör, İstanbul Üniversitesi Basımevi Ve Film Merkezi, İstanbul, ss.59-64, 1994

3. Chlamydia İnfeksiyonlarının Tedavisi

Chlamydia İnfeksiyonları ve Tanıda Yenilikler, Anğ Ö, Badur S, Ağaçfidan A , Editör, Türk Mikrobiyoloji Cemiyeti Yayını, İstanbul, ss.79-87, 1994
Metrikler

Yayın

188

Yayın (WoS)

166

Yayın (Scopus)

127

Atıf (WoS)

2408

H-İndeks (WoS)

26

Atıf (Scopus)

2603

H-İndeks (Scopus)

26

Atıf (Scholar)

20

H-İndeks (Scholar)

1

Proje

1

Tez Danışmanlığı

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları